TNA Therapeutics
James F. is a highly experienced professional in the pharmaceutical and biotech industry. James currently serves as the Chairman & Chief Executive Officer at TNA Therapeutics. Previously, James held leadership roles at companies such as Tripp & Associates, GLG, Ascentage Pharma, Glenmark Pharmaceuticals, Tiziana Life Sciences, RASNA THERAPEUTICS LIMITED, Novo Nordisk, Regeneron Pharmaceuticals, and Merck. James F. has a solid educational background with graduate studies in Health and Policy Management from Harvard T.H. Chan School of Public Health, Molecular Biology from Harvard University, and a Bachelor of Science in Psychology/Biology (Dual major) with a minor in Business from Iona University.
This person is not in any teams
This person is not in any offices
TNA Therapeutics
We are developing cancer treatments that specifically target the cancer stem cell population in tumors. Targeting these cells will prevent relapse and disease progression leading to long-term patient benefit. Meet with us: investormeeting@tnatherapeutics.com